PYYX PYXUS INTERNATIONAL, INC.
Wholesale-Farm Product Raw Materials · OTC · SEC CIK 939930 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.2%
TTM net income YoY1,052.9%
TTM EPS YoY1,008.3%
Revenue 3-yr CAGR2.1%
Net income 3-yr CAGR—
Margins
Gross margin14.5%
Operating margin6.5%
Net margin1.2%
FCF margin-6.7%
EBITDA margin7.5%
Returns
ROE17.7%
ROA1.4%
ROIC (approx.)5.3%
Asset turnover1.15x
Leverage & solvency
Liabilities / assets91.3%
Debt / equity7.83x
Current ratio1.30x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-4.59x
Accruals ratio7.8%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 | FY20242024-03-31 | FY20232023-03-31 | FY20222022-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.41B | $2.48B | $2.03B | $1.91B | $1.64B |
| Cost of revenue | $2.07B | $2.14B | $1.72B | $1.65B | $1.41B |
| Gross profit | $347.68M | $342.98M | $312.33M | $261.02M | $227.06M |
| SG&A expense | $162.93M | $171.00M | $160.91M | $151.53M | $142.02M |
| Operating income | $162.70M | $153.32M | $137.19M | $93.78M | $41.72M |
| Pretax income | $28.63M | $33.45M | $15.47M | -$22.62M | -$79.36M |
| Income tax | $30.34M | $25.05M | $27.28M | $34.13M | $12.64M |
| Net income | $14.57M | $15.17M | $2.66M | -$39.14M | -$82.12M |
| EBITDA | $183.59M | $173.65M | $156.44M | $112.92M | $58.39M |
| EPS (basic) | 0.56 | 0.59 | 0.11 | -1.57 | -3.28 |
| EPS (diluted) | 0.56 | 0.59 | 0.11 | -1.57 | -3.28 |
| Weighted avg. shares (diluted) | 25.96M | 25.67M | 25.00M | 25.00M | 25.00M |
| Banking | |||||
| Net interest income | -$134.35M | -$128.04M | -$125.62M | -$113.16M | -$108.38M |
| Balance sheet | |||||
| Cash & equivalents | $134.34M | $78.25M | $92.57M | $136.73M | $198.78M |
| Receivables | $239.46M | $189.24M | $168.76M | $185.35M | $247.68M |
| Current assets | $1.33B | $1.16B | $1.31B | $1.22B | $1.33B |
| PP&E, net | $143.15M | $138.18M | $134.16M | $133.40M | $137.52M |
| Goodwill | — | — | — | — | $0 |
| Intangibles | $24.08M | $28.51M | $33.88M | $38.57M | $45.06M |
| Total assets | $1.69B | $1.50B | $1.66B | $1.58B | $1.70B |
| Current liabilities | $932.77M | $773.95M | $905.16M | $715.06M | $814.37M |
| Short-term debt | $477.13M | $12,000 | $20.29M | $75,000 | $107.86M |
| Long-term debt | $455.76M | $454.85M | $497.73M | $618.43M | $580.48M |
| Total debt | $932.89M | $454.86M | $518.03M | $618.50M | $688.33M |
| Total liabilities | $1.51B | $1.34B | $1.51B | $1.44B | $1.52B |
| Shareholders' equity | $174.49M | $160.09M | $142.28M | $137.85M | $175.28M |
| Net debt | $798.55M | $376.61M | $425.46M | $481.77M | $489.56M |
| Shares outstanding | 24.61M | 24.61M | 25.00M | 25.00M | 25.00M |
| Cash flow statement | |||||
| Operating cash flow | -$208.45M | -$13.39M | -$214.97M | -$137.82M | -$198.76M |
| Capital expenditure | $22.05M | $23.03M | $21.04M | $16.31M | $14.83M |
| Free cash flow | -$230.50M | -$36.41M | -$236.01M | -$154.13M | -$213.59M |
| Investing cash flow | $191.42M | $170.64M | $159.45M | $154.94M | $181.24M |
| Financing cash flow | $72.52M | -$167.26M | $25.56M | -$83.00M | $123.26M |
| Depreciation & amortization | $20.89M | $20.33M | $19.25M | $19.14M | $16.68M |
| Stock-based compensation | $1.02M | $4.11M | $0 | $0 | — |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.